IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kvanta, A.
Right arrow Articles by Seregard, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kvanta, A.
Right arrow Articles by Seregard, S.

Investigative Ophthalmology & Visual Science, Vol 37, 1929-1934, Copyright © 1996 by Association for Research in Vision and Ophthalmology

ARTICLES AND REPORTS

Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor

A Kvanta, PV Algvere, L Berglin and S Seregard
Department of Ophthalmology, St. Erik's Eye Hospital, Stockholm, Sweden.

PURPOSE. Vascular endothelial growth factor (VEGF) is a potent and specific angiogenic growth factor, in vitro and in vivo, that may be associated with the development of intraocular neovascularization. In the current study, the authors analyze the expression of VEGF in subfoveal fibrovascular membranes from patients with age-related macular degeneration. METHODS. Surgically removed subfoveal fibrovascular membranes from 18 eyes were analyzed for the expression of VEGF mRNA and protein using in situ hybridization and immunohistochemistry, respectively. RESULTS. Most specimens expressed both VEGF mRNA and protein. The VEGF mRNA expression was particularly high in areas with a marked inflammatory response, in which the expression was concentrated to cells resembling fibroblasts and to surrounding inflammatory cells. VEGF protein expression was seen in fibrovascular parts of the membranes and was predominantly localized to the cytoplasm of fibroblastlike cells. In some of these membranes, strong VEGF protein immunoreactivity also was concentrated to extracellular matrix foci within the fibrovascular stroma. CONCLUSIONS. Results indicate that VEGF may be of pathogenetic importance for the development of the choroidal neovascularization (age-related macular degeneration) and also may implicate a role of fibroblasts of presumable choroidal origin in this process.


This article has been cited by other articles:


Home page
 Br. J. Ophthalmol.Home page
C G Kiss, C Simader, S Michels, and U Schmidt-Erfurth
Combination of verteporfin photodynamic therapy and ranibizumab: effects on retinal anatomy, choroidal perfusion and visual function in the protect study
Br. J. Ophthalmol., December 1, 2008; 92(12): 1620 - 1627.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
H. Nakashizuka, M. Mitsumata, S. Okisaka, H. Shimada, A. Kawamura, R. Mori, and M. Yuzawa
Clinicopathologic Findings in Polypoidal Choroidal Vasculopathy
Invest. Ophthalmol. Vis. Sci., November 1, 2008; 49(11): 4729 - 4737.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
N Lois, E Abdelkader, K Reglitz, C Garden, and J G Ayres
Environmental tobacco smoke exposure and eye disease
Br. J. Ophthalmol., October 1, 2008; 92(10): 1304 - 1310.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
D Iwama, A Otani, M Sasahara, Y Yodoi, N Gotoh, H Tamura, A Tsujikawa, and N Yoshimura
Photodynamic therapy combined with low-dose intravitreal triamcinolone acetonide for age-related macular degeneration refractory to photodynamic therapy alone
Br. J. Ophthalmol., October 1, 2008; 92(10): 1352 - 1356.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
S. Kaempf, S. Johnen, A. K. Salz, A. Weinberger, P. Walter, and G. Thumann
Effects of Bevacizumab (Avastin) on Retinal Cells in Organotypic Culture
Invest. Ophthalmol. Vis. Sci., July 1, 2008; 49(7): 3164 - 3171.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
A C Browning, H S Dua, and W M Amoaku
The effects of growth factors on the proliferation and in vitro angiogenesis of human macular inner choroidal endothelial cells
Br. J. Ophthalmol., July 1, 2008; 92(7): 1003 - 1008.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M. A. Economou, J. Wu, D. Vasilcanu, L. Rosengren, C. All-Ericsson, I. van der Ploeg, E. Menu, L. Girnita, M. Axelson, O. Larsson, et al.
Inhibition of VEGF Secretion and Experimental Choroidal Neovascularization by Picropodophyllin (PPP), an Inhibitor of the Insulin-like Growth Factor-1 Receptor
Invest. Ophthalmol. Vis. Sci., June 1, 2008; 49(6): 2620 - 2626.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
K. Izumi-Nagai, N. Nagai, K. Ohgami, S. Satofuka, Y. Ozawa, K. Tsubota, S. Ohno, Y. Oike, and S. Ishida
Inhibition of Choroidal Neovascularization with an Anti-Inflammatory Carotenoid Astaxanthin
Invest. Ophthalmol. Vis. Sci., April 1, 2008; 49(4): 1679 - 1685.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
C. Campa, I. Kasman, W. Ye, W. P. Lee, G. Fuh, and N. Ferrara
Effects of an Anti-VEGF-A Monoclonal Antibody on Laser-Induced Choroidal Neovascularization in Mice: Optimizing Methods to Quantify Vascular Changes
Invest. Ophthalmol. Vis. Sci., March 1, 2008; 49(3): 1178 - 1183.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M. Ju, C. Mailhos, J. Bradley, T. Dowie, M. Ganley, G. Cook, P. Calias, N. Lange, A. P. Adamis, D. T. Shima, et al.
Simultaneous but Not Prior Inhibition of VEGF165 Enhances the Efficacy of Photodynamic Therapy in Multiple Models of Ocular Neovascularization
Invest. Ophthalmol. Vis. Sci., February 1, 2008; 49(2): 662 - 670.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
O. Tatar, K. Shinoda, E. Kaiserling, G. Pertile, C. Eckardt, A. Mohr, E. Yoeruek, P. Szurman, K. U. Bartz-Schmidt, and S. Grisanti
Early Effects of Triamcinolone on Vascular Endothelial Growth Factor and Endostatin in Human Choroidal Neovascularization
Arch Ophthalmol, February 1, 2008; 126(2): 193 - 199.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
K. Izumi-Nagai, N. Nagai, K. Ohgami, S. Satofuka, Y. Ozawa, K. Tsubota, K. Umezawa, S. Ohno, Y. Oike, and S. Ishida
Macular Pigment Lutein Is Antiinflammatory in Preventing Choroidal Neovascularization
Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2555 - 2562.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
K. M. Nishiguchi, M. Nakamura, H. Kaneko, S. Kachi, and H. Terasaki
The Role of VEGF and VEGFR2/Flk1 in Proliferation of Retinal Progenitor Cells in Murine Retinal Degeneration
Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4315 - 4320.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
T. Koto, N. Nagai, H. Mochimaru, T. Kurihara, K. Izumi-Nagai, S. Satofuka, H. Shinoda, K. Noda, Y. Ozawa, M. Inoue, et al.
Eicosapentaenoic Acid Is Anti-Inflammatory in Preventing Choroidal Neovascularization in Mice
Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4328 - 4334.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
J. L. Olson, R. J. Courtney, and N. Mandava
Intravitreal Infliximab and Choroidal Neovascularization in an Animal Model
Arch Ophthalmol, September 1, 2007; 125(9): 1221 - 1224.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
M. Luke, K. Januschowski, M. Warga, J. Beutel, M. Leitritz, F. Gelisken, S. Grisanti, T. Schneider, C. Luke, K. U. Bartz-Schmidt, et al.
The retinal tolerance to bevacizumab in co-application with a recombinant tissue plasminogen activator
Br. J. Ophthalmol., August 1, 2007; 91(8): 1077 - 1082.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
Z.-M. Bian, S. G. Elner, and V. M. Elner
Thrombin-Induced VEGF Expression in Human Retinal Pigment Epithelial Cells
Invest. Ophthalmol. Vis. Sci., June 1, 2007; 48(6): 2738 - 2746.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
K. Izumi-Nagai, N. Nagai, Y. Ozawa, M. Mihara, Y. Ohsugi, T. Kurihara, T. Koto, S. Satofuka, M. Inoue, K. Tsubota, et al.
Interleukin-6 Receptor-Mediated Activation of Signal Transducer and Activator of Transcription-3 (STAT3) Promotes Choroidal Neovascularization
Am. J. Pathol., June 1, 2007; 170(6): 2149 - 2158.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
M. Bolz, S. Michels, W. Geitzenauer, F. Prager, and U. Schmidt-Erfurth
Effect of systemic bevacizumab therapy on retinal pigment epithelial detachment
Br. J. Ophthalmol., June 1, 2007; 91(6): 785 - 789.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M.-F. Zuluaga, C. Mailhos, G. Robinson, D. T. Shima, R. Gurny, and N. Lange
Synergies of VEGF Inhibition and Photodynamic Therapy in the Treatment of Age-Related Macular Degeneration
Invest. Ophthalmol. Vis. Sci., April 1, 2007; 48(4): 1767 - 1772.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
U. U. Inan, B. Avci, T. Kusbeci, B. Kaderli, R. Avci, and S. G. Temel
Preclinical Safety Evaluation of Intravitreal Injection of Full-Length Humanized Vascular Endothelial Growth Factor Antibody in Rabbit Eyes
Invest. Ophthalmol. Vis. Sci., April 1, 2007; 48(4): 1773 - 1781.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
R B Bhisitkul
Vascular endothelial growth factor biology: clinical implications for ocular treatments.
Br. J. Ophthalmol., December 1, 2006; 90(12): 1542 - 1547.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
P. J. Rosenfeld, D. M. Brown, J. S. Heier, D. S. Boyer, P. K. Kaiser, C. Y. Chung, R. Y. Kim, and the MARINA Study Group
Ranibizumab for Neovascular Age-Related Macular Degeneration
N. Engl. J. Med., October 5, 2006; 355(14): 1419 - 1431.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
R. A. Costa, R. Jorge, D. Calucci, J. A. Cardillo, L. A. S. Melo Jr, and I. U. Scott
Intravitreal Bevacizumab for Choroidal Neovascularization Caused by AMD (IBeNA Study): Results of a Phase 1 Dose-Escalation Study.
Invest. Ophthalmol. Vis. Sci., October 1, 2006; 47(10): 4569 - 4578.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
M Luke, M Warga, F Ziemssen, F Gelisken, S Grisanti, T Schneider, C Luke, M Partsch, K U Bartz-Schmidt, P Szurman, et al.
Effects of bevacizumab on retinal function in isolated vertebrate retina
Br. J. Ophthalmol., September 1, 2006; 90(9): 1178 - 1182.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
S. M. Cashman, L. Bowman, J. Christofferson, and R. Kumar-Singh
Inhibition of Choroidal Neovascularization by Adenovirus-Mediated Delivery of Short Hairpin RNAs Targeting VEGF as a Potential Therapy for AMD.
Invest. Ophthalmol. Vis. Sci., August 1, 2006; 47(8): 3496 - 3504.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
I. Semkova, S. Fauser, A. Lappas, N. Smyth, N. Kociok, B. Kirchhof, M. Paulsson, V. Poulaki, and A. M. Joussen
Overexpression of FasL in retinal pigment epithelial cells reduces choroidal neovascularization
FASEB J, August 1, 2006; 20(10): 1689 - 1691.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
B Zhao, A Ma, J Cai, and M Boulton
VEGF-A regulates the expression of VEGF-C in human retinal pigment epithelial cells
Br. J. Ophthalmol., August 1, 2006; 90(8): 1052 - 1059.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
H. J. Zambarakji, T. Nakazawa, E. Connolly, A. M. Lane, S. Mallemadugula, M. Kaplan, N. Michaud, A. Hafezi-Moghadam, E. S. Gragoudas, and J. W. Miller
Dose-dependent effect of pitavastatin on VEGF and angiogenesis in a mouse model of choroidal neovascularization.
Invest. Ophthalmol. Vis. Sci., June 1, 2006; 47(6): 2623 - 2631.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
O. Tatar, E. Kaiserling, A. Adam, F. Gelisken, K. Shinoda, M. Volker, B. A. Lafaut, K. U. Bartz-Schmidt, and S. Grisanti
Consequences of verteporfin photodynamic therapy on choroidal neovascular membranes.
Arch Ophthalmol, June 1, 2006; 124(6): 815 - 823.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
I. K. Kim, D. Husain, N. Michaud, E. Connolly, A. M. Lane, K. Durrani, A. Hafezi-Moghadam, E. S. Gragoudas, C. A. O'Neill, J. C. Beyer, et al.
Effect of Intravitreal Injection of Ranibizumab in Combination with Verteporfin PDT on Normal Primate Retina and Choroid
Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 357 - 363.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
S. He, Y. Ding, J. Zhou, V. Krasnoperov, S. Zozulya, S. R. Kumar, S. J. Ryan, P. S. Gill, and D. R. Hinton
Soluble EphB4 Regulates Choroidal Endothelial Cell Function and Inhibits Laser-Induced Choroidal Neovascularization
Invest. Ophthalmol. Vis. Sci., December 1, 2005; 46(12): 4772 - 4779.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
S. S. Dandekar, S. A. Jenkins, T. Peto, H. P. N. Scholl, K. S. Sehmi, F. W. Fitzke, A. C. Bird, and A. R. Webster
Autofluorescence Imaging of Choroidal Neovascularization Due to Age-Related Macular Degeneration
Arch Ophthalmol, November 1, 2005; 123(11): 1507 - 1513.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
L. Robman, O. Mahdi, C. McCarty, P. Dimitrov, G. Tikellis, J. McNeil, G. Byrne, H. Taylor, and R. Guymer
Exposure to Chlamydia pneumoniae Infection and Progression of Age-related Macular Degeneration
Am. J. Epidemiol., June 1, 2005; 161(11): 1013 - 1019.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
X.-F. Wang, J. Z. Cui, S. S. Prasad, and J. A. Matsubara
Altered Gene Expression of Angiogenic Factors Induced by Calcium-Mediated Dissociation of Retinal Pigment Epithelial Cells
Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1508 - 1515.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
C. Lebherz, A. M. Maguire, A. Auricchio, W. Tang, T. S. Aleman, Z. Wei, R. Grant, A. V. Cideciyan, S. G. Jacobson, J. M. Wilson, et al.
Nonhuman Primate Models for Diabetic Ocular Neovascularization Using AAV2-Mediated Overexpression of Vascular Endothelial Growth Factor
Diabetes, April 1, 2005; 54(4): 1141 - 1149.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
P. van Wijngaarden, D. J. Coster, and K. A. Williams
Inhibitors of Ocular Neovascularization: Promises and Potential Problems
JAMA, March 23, 2005; 293(12): 1509 - 1513.
[Full Text] [PDF]

Home page
 IOVSHome page
J. Gaudreault, D. Fei, J. Rusit, P. Suboc, and V. Shiu
Preclinical Pharmacokinetics of Ranibizumab (rhuFabV2) after a Single Intravitreal Administration
Invest. Ophthalmol. Vis. Sci., February 1, 2005; 46(2): 726 - 733.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
M. G. Slomiany and S. A. Rosenzweig
Autocrine effects of IGF-I-induced VEGF and IGFBP-3 secretion in retinal pigment epithelial cell line ARPE-19
Am J Physiol Cell Physiol, September 1, 2004; 287(3): C746 - C753.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M. G. Slomiany and S. A. Rosenzweig
IGF-1-Induced VEGF and IGFBP-3 Secretion Correlates with Increased HIF-1{alpha} Expression and Activity in Retinal Pigment Epithelial Cell Line D407
Invest. Ophthalmol. Vis. Sci., August 1, 2004; 45(8): 2838 - 2847.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
M Matsuoka, N Ogata, T Otsuji, T Nishimura, K Takahashi, and M Matsumura
Expression of pigment epithelium derived factor and vascular endothelial growth factor in choroidal neovascular membranes and polypoidal choroidal vasculopathy
Br. J. Ophthalmol., June 1, 2004; 88(6): 809 - 815.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
M. A. Zarbin
Current Concepts in the Pathogenesis of Age-Related Macular Degeneration
Arch Ophthalmol, April 1, 2004; 122(4): 598 - 614.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
H. J. Koh, K. Bessho, L. Cheng, D.-U. Bartsch, T. R. Jones, G. Bergeron-Lynn, and W. R. Freeman
Inhibition of Choroidal Neovascularization in Rats by the Urokinase-Derived Peptide A6
Invest. Ophthalmol. Vis. Sci., February 1, 2004; 45(2): 635 - 640.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
M. Tomita, H. Yamada, Y. Adachi, Y. Cui, E. Yamada, A. Higuchi, K. Minamino, Y. Suzuki, M. Matsumura, and S. Ikehara
Choroidal Neovascularization Is Provided by Bone Marrow Cells
Stem Cells, January 1, 2004; 22(1): 21 - 26.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
Y. Saishin, R. L. Silva, Y. Saishin, K. Callahan, C. Schoch, M. Ahlheim, H. Lai, F. Kane, R. K. Brazzell, D. Bodmer, et al.
Periocular Injection of Microspheres Containing PKC412 Inhibits Choroidal Neovascularization in a Porcine Model
Invest. Ophthalmol. Vis. Sci., November 1, 2003; 44(11): 4989 - 4993.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
U. Schmidt-Erfurth, U. Schlotzer-Schrehard, C. Cursiefen, S. Michels, A. Beckendorf, and G. O. H. Naumann
Influence of Photodynamic Therapy on Expression of Vascular Endothelial Growth Factor (VEGF), VEGF Receptor 3, and Pigment Epithelium-Derived Factor
Invest. Ophthalmol. Vis. Sci., October 1, 2003; 44(10): 4473 - 4480.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
J.-M. Rakic, V. Lambert, L. Devy, A. Luttun, P. Carmeliet, C. Claes, L. Nguyen, J.-M. Foidart, A. Noel, and C. Munaut
Placental Growth Factor, a Member of the VEGF Family, Contributes to the Development of Choroidal Neovascularization
Invest. Ophthalmol. Vis. Sci., July 1, 2003; 44(7): 3186 - 3193.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
M. V. Kalayoglu, C. Galvan, O. S. Mahdi, G. I. Byrne, and S. Mansour
Serological Association Between Chlamydia pneumoniae Infection and Age-Related Macular Degeneration
Arch Ophthalmol, April 1, 2003; 121(4): 478 - 482.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
P. M. Stuart, F. Pan, S. Plambeck, and T. A. Ferguson
FasL-Fas Interactions Regulate Neovascularization in the Cornea
Invest. Ophthalmol. Vis. Sci., January 1, 2003; 44(1): 93 - 98.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
K. G. Carrasquillo, J. A. Ricker, I. K. Rigas, J. W. Miller, E. S. Gragoudas, and A. P. Adamis
Controlled Delivery of the Anti-VEGF Aptamer EYE001 with Poly(lactic-co-glycolic)Acid Microspheres
Invest. Ophthalmol. Vis. Sci., January 1, 2003; 44(1): 290 - 299.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
L. Berglin, S. Sarman, I. van der Ploeg, B. Steen, Y. Ming, S. Itohara, S. Seregard, and A. Kvanta
Reduced Choroidal Neovascular Membrane Formation in Matrix Metalloproteinase-2-Deficient Mice
Invest. Ophthalmol. Vis. Sci., January 1, 2003; 44(1): 403 - 408.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
J. L. Gottlieb
Age-Related Macular Degeneration
JAMA, November 13, 2002; 288(18): 2233 - 2236.
[Full Text] [PDF]

Home page
 Arch OphthalmolHome page
U. Schmidt-Erfurth, H. Laqua, U. Schlotzer-Schrehard, A. Viestenz, and G. O. H. Naumann
Histopathological Changes Following Photodynamic Therapy in Human Eyes
Arch Ophthalmol, June 1, 2002; 120(6): 835 - 844.
[Full Text] [PDF]

Home page
 IOVSHome page
N. Ogata, M. Wada, T. Otsuji, N. Jo, J. Tombran-Tink, and M. Matsumura
Expression of Pigment Epithelium-Derived Factor in Normal Adult Rat Eye and Experimental Choroidal Neovascularization
Invest. Ophthalmol. Vis. Sci., April 1, 2002; 43(4): 1168 - 1175.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
U. Schmidt-Erfurth, S. Michels, I. Barbazetto, and H. Laqua
Photodynamic Effects on Choroidal Neovascularization and Physiological Choroid
Invest. Ophthalmol. Vis. Sci., March 1, 2002; 43(3): 830 - 841.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
M. G. Krzystolik, M. A. Afshari, A. P. Adamis, J. Gaudreault, E. S. Gragoudas, N. A. Michaud, W. Li, E. Connolly, C. A. O'Neill, and J. W. Miller
Prevention of Experimental Choroidal Neovascularization With Intravitreal Anti-Vascular Endothelial Growth Factor Antibody Fragment
Arch Ophthalmol, March 1, 2002; 120(3): 338 - 346.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
C. Guidry, N. E. Medeiros, and C. A. Curcio
Phenotypic Variation of Retinal Pigment Epithelium in Age-Related Macular Degeneration
Invest. Ophthalmol. Vis. Sci., January 1, 2002; 43(1): 267 - 273.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
A. Obana, Y. Gohto, K. Kaneda, S. Nakajima, and T. Miki
PDT to Monkey CNV with ATX-S10(Na): Inappropriateness of Early Laser Irradiation for Selective Occlusion
Invest. Ophthalmol. Vis. Sci., October 1, 2001; 42(11): 2639 - 2645.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
C.-C. Lai, W.-C. Wu, S.-L. Chen, X. Xiao, T.-C. Tsai, S.-J. Huan, T.-L. Chen, R. J.-F. Tsai, and Y.-P. Tsao
Suppression of Choroidal Neovascularization by Adeno-associated Virus Vector Expressing Angiostatin
Invest. Ophthalmol. Vis. Sci., September 1, 2001; 42(10): 2401 - 2407.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M. Hangai, T. Murata, N. Miyawaki, C. Spee, J. I. Lim, S. He, D. R. Hinton, and S. J. Ryan
Angiopoietin-1 Upregulation by Vascular Endothelial Growth Factor in Human Retinal Pigment Epithelial Cells
Invest. Ophthalmol. Vis. Sci., June 1, 2001; 42(7): 1617 - 1625.
[Abstract] [Full Text]

Home page